Adams Pulls Off Trade For Mucinex Complement
This article was originally published in The Tan Sheet
Executive Summary
Adams Respiratory Therapeutics is expanding its guaifenesin cough/cold portfolio with the addition of Cornerstone BioPharma's Humibid line